Infectious in Medical Technology

Cepheid Receives Grant to Develop Ten-Color Real-Time PCR Detection Technology for Use in the GeneXpert(R) System

... award from the National Institute of Allergy and infectious Diseases to develop new ten-color detection ... is expected to deliver more cost-effective infectious disease panel testing applications by increasing ... and oncology tests. "The workup of many infectious conditions requires considerable guesswork on the ...

Aethlon Medical to Present at the 2009 RedChip Small-Cap Investor Conference on June 16, 2009

... adjunct to the immune system proven to capture infectious viruses and immunosuppressive particles from the ... improve the health of individuals afflicted with infectious disease and cancer. Aethlon's lead product, the ... adjunct to the immune system proven to capture infectious viruses and immunosuppressive particles from the ...

Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection

... European Congress of Clinical Microbiology and infectious Diseases (ECCMID) meeting in Helsinki , ... European Congress of Clinical Microbiology and infectious Diseases (ECCMID) in Helsinki, Finland. ... as treatment for this serious and common cause of infectious diarrhea," said Thomas J. Louie, M.D., Medical ...

Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus

... today announced that its Focus Diagnostics infectious disease reference laboratory has introduced a ... with new laboratory testing services for emerging infectious diseases, such as West Nile Virus, SARS, and ... and develop diagnostic tests for emerging infectious diseases. Focus Diagnostics was instrumental in ...

Progress Against Malaria and Other Infectious Diseases Among Highlights at Annual Vaccine Conference

... (ACVR), sponsored by the National Foundation for infectious Diseases (NFID) April 27-29, 2009 in Baltimore. ... honor Paul A. Offit, MD, chief of the division of infectious disease at Children's Hospital of Philadelphia, ... his life to vaccines for the prevention of infectious disease. The company he developed from his ...

Intercell Starts a Phase I Clinical Trial for a New Streptococcus pneumoniae Vaccine

... position in the development of vaccines against infectious diseases with significant unmet medical need," ... vaccines for the prevention and treatment of infectious diseases with substantial unmet medical needs. ... I). In addition, three other products focused on infectious diseases are in pre-clinical development. ...

CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency

... Products made from human plasma may contain infectious agents (e.g., viruses and theoretically the ... The risk that such products will transmit an infectious agent has been reduced by screening plasma donors ... There is also the possibility that unknown infectious agents may be present in such products. The ...

GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA

... by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, announced the first injections in its ... by the National Institutes of Allergy and infectious Diseases (NIAID), is the largest worldwide ... by HIV-1 (Human Immunodeficiency Virus) and other infectious agents. GeoVax's AIDS vaccine technology is the ...

Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile

... broadest range of vaccines protecting against 20 infectious diseases. The company's heritage, to ... 2. O'Brien et al, The Emerging infectious Challenge of Clostridium difficile-Associated ... America and Europe, Clinical Microbiology and infectious Diseases, 2006; 12 (Suppl. 6): 2-18 4. ...

Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program

... awarded by the National Institute of Allergy and infectious Diseases (NIAID), National Institutes of Health ... or vaccines that address emerging and re-emerging infectious tropical diseases and bioweapon pathogens. The ... its global influence, R&D platforms and infectious disease expertise to proactively address emerging ...

Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans

... awarded by the National Institute of Allergy and infectious Diseases (NIAID), part of the National Institutes ... DNA delivery technology include DNA vaccines for infectious diseases or cancer, in which the expressed ... growth factor. The company is developing certain infectious disease vaccines and cancer therapeutics ...

SARS Vaccine Achieves Neutralizing Responses in First U.S. Human Trial

... Center (VRC), National Institute of Allergy and infectious Diseases (NIAID), NIH, and manufactured by Vical. ... a potential vaccine platform for future emerging infectious diseases." After completion of the NIH ... when a medical need arises. "Like many emerging infectious diseases, SARS is suspected of having origins in ...

Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial

... and now encompasses vaccine candidates against infectious diseases and cancer, cancer immunotherapies, and ... DNA delivery technology include DNA vaccines for infectious diseases or cancer, in which the expressed ... growth factor. The company is developing certain infectious disease vaccines and cancer therapeutics ...

Medarex Announces Initiation of Phase 1b Clinical Development Program with MDX-1106 for the Treatment of Cancer

... specific T-cells in both the oncology and chronic infectious disease settings, as well as a strong correlation ... promote an immune response to fight tumors and infectious diseases. As previously presented at ... is being investigated in both the oncology and infectious disease settings. In addition to the Phase 1b ...

Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome

... 2008. (iii) Sakoulas, G et al. Clinical infectious Diseases 2006; 42: S40-S50. (iv) Tenover F, Moellering RC Jr. Clinical infectious Diseases 2007; 44: 1208-15. (v) Centers ... 2008. (vi) Kuehnert MJ et al. Emerging infectious Diseases 2005; 11: 868-72. (vii) Klevens, ...

Sequella Presents Data on Synergy Between Investigational New TB Drugs SQ109 and TMC207

... focused on commercializing products to treat infectious diseases of epidemic potential, announces ... Agents and Chemotherapeutics (ICAAC) and infectious Disease Society of America (IDSA) joint meeting ... on commercializing improved treatments for infectious diseases of epidemic potential. The company ...

Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections

... i Kuehnert MJ et al. Journal of infectious Diseases. 2006; 193: 172-9. ii ... 22, 2008. v Sakoulas, G et al. Clinical infectious Diseases 2006; 42: S40-S50. vi Tenover F, Moellering RC Jr. Clinical infectious Diseases 2007; 44: 1208-15. vii Centers ...

Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay

... Chemotherapy (ICAAC) / 46th Annual Meeting of the infectious Diseases Society of America (IDSA) in ... said W. David Hardy, MD, Director, Division of infectious Diseases at Cedars-Sinai Medical Center and ... to guide and improve treatment of serious infectious diseases and cancer. The Company's products ...

Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests

... liver). Hepatitis B virus is 50 to 100 times more infectious than HIV. Most people who develop ... include a wide range of various infectious disease tests for Chlamydia, Gonorrhea, Syphilis, ... relevant issues, including naturally occurring infectious diseases, combat casualty care operational health ...

Physicians Estimate That if Approved, Ceftobiprole Will Steal Nearly a Third of Zyvox's Patient Share in the Treatment of Nosocomial Pneumonia

... Pneumonia Prescribing in Hospitals Are infectious Disease Consults and ATS/IDSA Guidelines ... states John Lebbos, M.D., Vice President of infectious Diseases at Decision Resources. "Physicians ... patterns are mainly driven by an institution's infectious disease consults and by guidelines presented by ...

Napo Announces Positive Clinical Data Indicating Crofelemer, Could Effectively Treat Cholera

... funded by the National Institutes of Allergy and infectious Disease. Napo is currently conducting a Phase 3 ... to the treatment with crofelemer of acute infectious diarrhea of multiple etiologies in adult patients ... or oral, and antibiotic therapy to target the infectious agent. There are no current therapies for ...

BioVex Announces Regulatory Clearance to Commence a Clinical Study With ImmunoVEX HSV2; A Vaccine Candidate for Genital Herpes

... stage treatments for cancer and the prevention of infectious disease, today announced the UK Medicines and ... testing the safety and immunogenicity of its lead infectious disease candidate for genital herpes, ImmunoVEX ... for the treatment of cancer and prevention of infectious disease. The Company's lead cancer technology ...

Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control

... medical university, and the Swedish Institute for infectious Disease Control (SMI), a governmental ... plasmid DNA ring, and cannot reconstitute into an infectious virus. The HIV DNA vaccine was developed by the ... DNA vaccines and conventional vaccines against infectious diseases and cancer. About Vical Vical ...

Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control

... medical university, and the Swedish Institute for infectious Disease Control (SMI), a governmental expert ... plasmid DNA ring, and cannot reconstitute into an infectious virus. The HIV DNA vaccine was developed by the ... DNA vaccines and conventional vaccines against infectious diseases and cancer. About Vical Vical ...

Study Shows Use of AdvanDx's PNA FISH(TM) Test was Associated with an 82% Reduction in Intensive Care Unit Mortality Rates from Staphylococcus aureus Bloodstream Infections

... was undertaken by clinicians in the Section of infectious Diseases at Washington Hospital Center (WHC) in ... said lead author Shmuel Shoham, M.D., Section of infectious Diseases and Director of Transplant infectious Diseases at Washington Hospital Center. "There ...

Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH

... by the National Institute of Allergy and infectious Diseases (NIAID), part of the National Institutes ... development against pandemic influenza and other infectious diseases at Vical, are manufactured by bacterial ... emerging diseases during the early stages of an infectious outbreak and overcome the time, capacity and ...

Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over 3 Years for its Influenza Vaccine Global Stockpile

... Influenza is a disease caused by a highly infectious virus that spreads easily from person to person, ... epidemic of an especially virulent virus, newly infectious for humans, and for which there is no preexisting ... broadest range of vaccines protecting against 20 infectious diseases. The company's heritage, to create ...

Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine

... M.D., professor and director of the Center for infectious Diseases at The University of Texas School of ... and a breakthrough in the field of infectious disease. We look forward to targeting both the ... vaccines for the prevention and treatment of infectious diseases with substantial unmet medical need. The ...

Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development

... vaccine candidates against SARS and other complex infectious disease targets because many of these biological ... of our vaccine technology to a broad range of infectious diseases around the world," said Rahul Singhvi, ... novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary ...

Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization

... to chicks that had been infected with infectious Bronchitis Virus (IBV). The data from the study ... or prevent disease. Preventing and treating infectious bronchitis caused by IBV is a worldwide concern ... need for additional products to combat infectious Bronchitis (IBV). Dr Richard Rosenbloom, ...

Annual Conference on Vaccine Research to Highlight Not Only Health Benefits But Also Economic Gains

... introducing new vaccines against emerging infectious diseases, as well as other public-health ... Institute, National Institute for Allergy and infectious Diseases, The Netherlands Vaccine Institute and ... about the causes, treatment and prevention of infectious diseases. Contact: Jennifer Corrigan ...

Caliper Life Sciences' Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center

... System Provides Real-Time Insight on Viability of infectious Disease Treatment Options - ... tuberculosis is one of the most serious infectious diseases in the world. Caliper is dedicated to assisting the global fight against infectious diseases and aiding the discovery of life-saving ...

Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea

... for the treatment of acute adult infectious diarrhea) conducted by its partner, Glenmark ... dose. In conclusion, adult Indian patients with infectious diarrhea treated with crofelemer showed a faster ... In combination with previous success in treating infectious diarrhea in travelers in Mexico and Jamaica with ...

Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa

... Tuberculosis is the world's second deadliest infectious disease, with over 9 million new cases diagnosed ... in the fight against emerging and re-emerging infectious diseases, and in biodefense. The technology ... of vaccines and antibodies that prevent and treat infectious diseases. Its vaccines are sold in public and ...

Gates Foundation Seeks Proposals for Innovative Global Health Research

... bold, unconventional ideas to fight infectious diseases SEATTLE, March 3 /PRNewswire/ -- The ... -- Creating new ways to protect against infectious diseases: Untried or unproven approaches to protect against infectious diseases, including harnessing natural or ...

Influenza Vaccination Rates Among Health Care Personnel Remain Well Below National Goal

... National Foundation for infectious Diseases Highlights Critical Need for ... About the National Foundation for infectious Diseases The National Foundation for infectious Diseases (NFID) is a non-profit, tax-exempt ...

Focus Diagnostics Launches Laboratory Test for Chikungunya Virus

... Detecting the Mosquito-Borne infectious Disease CYPRESS, Calif., Feb. 15 /PRNewswire/ ... that physicians can use to diagnose emerging infectious diseases, such as West Nile Virus and SARS. ... A leader in diagnostic testing for emerging infectious diseases, Focus Diagnostics has collaborated with ...

New Data Show Unacceptably Low Adult Immunization Rates and That Adults Unaware of Infectious Disease Threat

... lack awareness of vaccines and the severity of infectious diseases. An expert panel discussed the data at ... conference held by the National Foundation for infectious Diseases (NFID), which called for increased use ... needless illness and deaths associated with infectious diseases. CDC's National Immunization Survey ...

Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway

... property that will enable development of infectious disease tests for the company's future ... property for the development of tests for infectious diseases including sepsis; hospital-acquired ... such as Chlamydia and Neisseria." infectious disease testing comprises about 50 percent of the ...

Glenmark Initiates Phase 2 Trial for Crofelemer for Acute Infectious Diarrhea

... trial for crofelemer for the indication of acute infectious diarrhea at two sites in India. This ... syndrome ("D-IBS"), Phase 2 -- CRO-ID for acute infectious diarrhea (including cholera), Phase 2 -- CRO-PED ... diarrhea, diarrhea-predominant IBS, and acute infectious diarrhea. It is generally well tolerated and has ...